Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Added to Propofol for DISE in OSA
NCT03091894Phase 4Completed
- Start
- Apr 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in obstructive sleep apnea (OSA) (2 arms). Primary endpoint: Success of sedation at 20 minutes. Started Apr 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03091894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091894.